| View |
|
DRP-2272
|
Atorvastatin (as Calcium)
|
Xantor
|
20 mg
|
Film-Coated Tablet
|
Antihyperlipidemic Agent
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
Automatic Renewal
|
01 March 2024
|
03 July 2029
|
| View |
|
DRP-2373-06
|
Folic Acid
|
Megafol
|
5 mg
|
Capsule
|
Vitamins / Hematinics
|
LIFESQUARE LABORATORIES INC
|
Philippines
|
CLIDP Conversion
|
01 March 2024
|
26 May 2029
|
| View |
|
DRP-2382-15
|
Ketorolac trometamol
|
Krytolac
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Opioid Analgesic
|
Myungmoon Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
02 February 2024
|
12 April 2025
|
| View |
|
DRP-2994-02
|
Cefuroxime (as axetil)
|
Zobexelle
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Akums Drugs & Pharmaceuticals, Ltd.
|
India
|
CLIDP Conversion
|
02 February 2024
|
09 June 2029
|
| View |
|
DRP-3087-18
|
Co-Amoxiclav
|
None
|
500 mg/125 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 March 2024
|
27 June 2029
|
| View |
|
DRP-3123-06
|
Atorvastatin (as Calcium)
|
Unbranded
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
16 April 2024
|
12 July 2029
|
| View |
|
DRP-3157-02
|
Sildenafil (as citrate)
|
Retafil
|
50 mg
|
Film-Coated Tablet
|
Urological (Drug used in Erectile Dysfunction)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 September 2024
|
11 August 2029
|
| View |
|
DRP-3431-09
|
Azithromycin (as Monohydrate)
|
Cinazith-DS
|
200 mg/5 mL
|
Suspension
|
Antibacterial (Macrolide)
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
Renewal
|
03 April 2024
|
07 December 2029
|
| View |
|
DRP-3555-09
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
PIPETECH
|
4 g / 500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.
|
China
|
Renewal
|
15 June 2024
|
26 August 2029
|
| View |
|
DRP-3590-05
|
Omeprazole (as Sodium)
|
Ometech
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitors
|
CSPC Ouyi Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
15 February 2024
|
14 July 2028
|
| View |
|
DRP-3590-07
|
Omeprazole (as Sodium)
|
Gomezole
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump Inhibitors
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
12 February 2024
|
14 July 2028
|
| View |
|
DRP-4116-05
|
Irinotecan hydrochloride
|
Irixtar
|
20 mg/mL
|
Solution for Injection (IV)
|
Antineoplastic (Cell cycle-specific agent)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
26 February 2024
|
03 November 2027
|
| View |
|
DRP-4207-09
|
Carbocisteine
|
Cistovent
|
500 mg
|
Capsule
|
Mucolytic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
06 February 2024
|
07 February 2027
|
| View |
|
DRP-4224-05
|
Guaifenesin + Salbutamol (as sulfate)
|
Xensal Plus
|
50 mg/ 1 mg per 5mL
|
Syrup
|
Expectorant / Anti-asthma
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 April 2024
|
28 July 2029
|
| View |
|
DRP-4295-04
|
Atorvastatin (as Calcium Trihydrate)
|
None
|
80 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
21 January 2024
|
13 March 2028
|
| View |
|
DRP-4324-05
|
Clindamycin (as phosphate)
|
Lincoxin
|
150 mg/mL (300 mg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Lincosamide)
|
United Biotech Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 February 2024
|
28 September 2027
|
| View |
|
DRP-4355-05
|
Clindamycin (as phosphate)
|
Lincoxin
|
150mg/mL (600 mg/4 mL)
|
Solution for Injection(I.M./I.V.)
|
Antibacterial(Lincosamide)
|
United Biotech Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 February 2024
|
28 September 2027
|
| View |
|
DRP-4762-09
|
Telmisartan
|
Terlisartan
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
15 February 2024
|
30 September 2028
|
| View |
|
DRP-4771-06
|
Co-Amoxiclav
|
Goxiclav
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Giyaan Pharma Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 February 2024
|
02 October 2028
|
| View |
|
DRP-4825-04
|
Clarithromycin
|
Klarex
|
250mg/5mL
|
Granules for Suspension
|
Antibacterial (Macrolide)
|
Medisure Laboratories Pakistan (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
24 January 2024
|
16 October 2028
|